Why is Kilitch Drugs falling/rising?

As of 03-September, Kilitch Drugs (India) Ltd is currently priced at 355.75, reflecting a slight increase of 0.15 or 0.04%. The stock has been gaining over the last three days, with a total return of 4.91% during this period. However, it has underperformed its sector by 1.2% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 60.69% compared to the 5-day average. The stock has shown a year-to-date increase of 10.14%, outperforming the Sensex, which has risen by only 3.11% in the same timeframe.
In the broader market context, while Kilitch Drugs has experienced a decline of 3.34% over the past week, the Sensex has only decreased by 0.27%, indicating a relative weakness in the stock's performance. Despite its strong long-term returns, including a 300.62% increase over the past five years compared to the Sensex's 106.63%, the recent short-term trends suggest challenges. The combination of falling investor participation and underperformance against sector benchmarks may contribute to a cautious outlook among investors, impacting the stock's price movement.